Nachrichten zur Opko Health Inc. Aktie

Opko Health (OPK) Q2 Revenue Falls 14%

Key PointsRevenue (GAAP) missed expectations, falling to $156.8 million in Q2 2025—down approximately 14% from the prior year quarter and…

Compared to Estimates, OPKO Health (OPK) Q2 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for OPKO Health (OPK) give a sense of how the business performed in the…

OPKO Health (OPK) Reports Q2 Loss, Lags Revenue Estimates

OPKO Health (OPK) delivered earnings and revenue surprises of -58.33% and -5.09%, respectively, for the quarter ended June 2025. Do…

OPKO Health (OPK) Reports Q1 Earnings: What Key Metrics Have to Say

The headline numbers for OPKO Health (OPK) give insight into how the company performed in the quarter ended March 2025,…

OPKO Health (OPK) Reports Q1 Loss, Lags Revenue Estimates

OPKO Health (OPK) delivered earnings and revenue surprises of -66.67% and 8.87%, respectively, for the quarter ended March 2025. Do…

Opko Health (OPK): Hauptaktionär Dr. Frost hat 2025 bereits Aktien für knapp 1,75 Mio. USD gekauft!

Opko Health Inc. (OPK) ist ein Gesundheitsspezialist, welcher sich u.a. auf diagnostische Tests über seine Tochtergesellschaft BioReference Laboratories, die jährlich…

OPKO Health (OPK): Vorstand nutzt die Konsolidierung um seine private Position um 1,1 Mio. USD zu vergrößern

OPKO Health Inc. (OPK) ist ein diversifiziertes Gesundheitsunternehmen, das sich auf die Entwicklung und Vermarktung von medizinischen Produkten und Dienstleistungen…

Opko Health (OPK) Q4 2024 Earnings Call Transcript

OPK earnings call for the period ending December 31, 2024.…

OPKO Health (OPK) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for OPKO Health (OPK) give a sense of how the business performed in the…

OPKO Health (OPK) Beats Q4 Earnings and Revenue Estimates

OPKO Health (OPK) delivered earnings and revenue surprises of 109.09% and 18.35%, respectively, for the quarter ended December 2024. Do…

OPKO Health (OPKO): CEO nutzt Konsolidierung zum Kauf von Aktien im Wert von rund 2,99 Mio. USD!

OPKO Health (OPKO) konzentriert sich auf Lösungen der nächsten Generation für schwere Erkrankungen auf etablierten globalen Märkten. Im Bereich der…

Opko Health Inc. (OPK): CEO beweist sein Vertrauen durch Aktienkäufe im Umfang von 1,05 Mio. USD!

Die Opko Health Inc. (OPK) ist ein diversifiziertes biopharmazeutisches und Diagnostikunternehmen. Der Fokus liegt auf der Entwicklung und Kommerzialisierung von…

Opko Health (OPK) Q3 2024 Earnings Call Transcript

OPK earnings call for the period ending September 30, 2024.…

ENTX & OPK Stock May Gain Following Positive PK/PD Research Data

Entera and OPKO Health announce positive PK/PD results from their ongoing collaborative research focused on developing the first oral dual…

Labcorp Stock Gains From Its Latest Acquisition of BioReference Health

LH completes the acquisition of BioReference Health, a wholly-owned subsidiary of OPKO Health. The acquisition includes BioReference Healths laboratory testing…

Opko Health (OPK) Q2 2024 Earnings Call Transcript

OPK earnings call for the period ending June 30, 2024.…

OPKO Health, Inc. (OPK) Q2 2024 Earnings Call Transcript

…

OPKO Health (OPK) Q2 Earnings Top Estimates, Gross Margin Down

Despite OPKO Healths (OPK) strength in the Diagnostics segment, its overall second-quarter results reflect soft performances.…

Opko Health (OPK) Q1 2024 Earnings Call Transcript

OPK earnings call for the period ending March 31, 2024.…

OPKO Health, Inc. (OPK) Q1 2024 Earnings Call Transcript

…

ROSEN, NATIONAL TRIAL LAWYERS, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AGL

NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AGL

NEW YORK, April 07, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AGL

NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

OPKO Health (OPK) to Restructure After Asset Buyout by Labcorp

OPKO Health (OPK) expects to re-establish profitability in its clinical laboratory business via its latest efforts to streamline its laboratory…

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AGL

NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…